Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) EBIT (2020 - 2025)

Historic EBIT for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $7.4 million.

  • LifeStance Health's EBIT rose 1566595.74% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 11096.81%. This contributed to the annual value of -$31.6 million for FY2024, which is 8328.54% up from last year.
  • Per LifeStance Health's latest filing, its EBIT stood at $7.4 million for Q3 2025, which was up 1566595.74% from -$2.9 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's EBIT registered a high of $7.4 million during Q3 2025, and its lowest value of -$124.7 million during Q3 2021.
  • Over the past 5 years, LifeStance Health's median EBIT value was -$34.1 million (recorded in 2023), while the average stood at -$37.4 million.
  • Per our database at Business Quant, LifeStance Health's EBIT tumbled by 4533557.69% in 2021 and then soared by 1566595.74% in 2025.
  • Quarter analysis of 5 years shows LifeStance Health's EBIT stood at -$113.8 million in 2021, then surged by 59.55% to -$46.0 million in 2022, then grew by 29.86% to -$32.3 million in 2023, then surged by 103.28% to $1.1 million in 2024, then surged by 599.72% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, -$2.9 million for Q2 2025, and $1.6 million during Q1 2025.